Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript

2025-05-12 21:06:52 ET

Sangamo Therapeutics, Inc. (SGMO)

Q1 2025 Earnings Conference Call

May 12, 2025, 06:30 PM ET

Company Participants

Louise Wilkie - Vice President, Investor Relations and Corporate Communications

Sandy Macrae - Chief Executive Officer

Nathalie Dubois-Stringfellow - Chief Development Officer

Prathyusha Duraibabu - Chief Financial Officer

Conference Call Participants

Nicole Germino - Truist

Luis Santos - H.C. Wainwright

Presentation

Operator

Good afternoon and welcome to the Sangamo Therapeutics First Quarter 2025 Teleconference Call. Please be advised that today's conference is being recorded....

Read the full article on Seeking Alpha

For further details see: